# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA5232878 | F | Antibacterial activity against methicillin sensitive Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs | Staphylococcus aureus | 30 | ALA5230166 | organism-based format | Scientific Literature | |
2. | ALA5232879 | F | Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 33591 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs | Staphylococcus aureus | 30 | ALA5230166 | organism-based format | Scientific Literature | |
3. | ALA5232880 | F | Antibacterial activity against clinical isolate methicillin resistant Staphylococcus epidermidis AB 735 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs | Staphylococcus epidermidis | 30 | ALA5230166 | organism-based format | Scientific Literature | |
4. | ALA5232881 | F | Antibacterial activity against vancomycin resistant Enterococcus faecalis ATCC 700802 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs | Enterococcus faecalis | 30 | ALA5230166 | organism-based format | Scientific Literature | |
5. | ALA5232882 | F | Antibacterial activity against Enterococcus faecium ATCC 49624 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs | Enterococcus faecium | 30 | ALA5230166 | organism-based format | Scientific Literature | |
6. | ALA5232883 | F | Antibacterial activity against clinical isolate Escherichia coli AB 117 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs | Escherichia coli | 30 | ALA5230166 | organism-based format | Scientific Literature | |
7. | ALA5232884 | F | Antibacterial activity against clinical isolate Klebsiella pneumoniae AB 356 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs | Klebsiella pneumoniae | 30 | ALA5230166 | organism-based format | Scientific Literature | |
8. | ALA5232885 | F | Antibacterial activity against clinical isolate Pseudomonas aeruginosa AB 645 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs | Pseudomonas aeruginosa | 30 | ALA5230166 | organism-based format | Scientific Literature | |
9. | ALA5232886 | F | Antibacterial activity against clinical isolate Acinetobacter baumannii BAA 747 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs | Acinetobacter baumannii | 30 | ALA5230166 | organism-based format | Scientific Literature | |
10. | ALA5232887 | F | Antibacterial activity against Moraxella catarrhalis ATCC 25238 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs | Moraxella catarrhalis | 30 | ALA5230166 | organism-based format | Scientific Literature | |
11. | ALA5232888 | F | Antibacterial activity against Mycobacterium smegmatis ATCC 607 assessed as inhibition of bacterial growth incubated for 2 days by CLSI protocol based broth microdilution method | Mycolicibacterium smegmatis | 29 | ALA5230166 | organism-based format | Scientific Literature | |
12. | ALA5232889 | F | Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as inhibition of bacterial growth incubated for 2 days by CLSI protocol based broth microdilution method | Mycobacterium tuberculosis | 29 | ALA5230166 | organism-based format | Scientific Literature | |
13. | ALA5232890 | F | Antibacterial activity multi-drug resistant Mycobacterium tuberculosis H37Rv ATCC 35822 assessed as inhibition of bacterial growth incubated for 2 days by CLSI protocol based broth microdilution method | Mycobacterium tuberculosis | 29 | ALA5230166 | organism-based format | Scientific Literature |